Contemporary trends in axillary surgery for ER-positive, HER2-negative breast cancer stratified by neoadjuvant endocrine therapy, neoadjuvant chemotherapy, or upfront surgery
Publication
, Conference
Douglas, S; Thomas, S; Chiba, A; DiNome, M; DiLalla, G; Hwang, ES; Parrish, K; Rosenberger, L; Plichta, J; Wang, T; van den Bruele, AB
Published in: ANNALS OF SURGICAL ONCOLOGY
2025
Duke Scholars
Published In
ANNALS OF SURGICAL ONCOLOGY
EISSN
1534-4681
ISSN
1068-9265
Publication Date
2025
Volume
32
Start / End Page
775 / 776
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Douglas, S., Thomas, S., Chiba, A., DiNome, M., DiLalla, G., Hwang, E. S., … van den Bruele, A. B. (2025). Contemporary trends in axillary surgery for ER-positive, HER2-negative breast cancer stratified by neoadjuvant endocrine therapy, neoadjuvant chemotherapy, or upfront surgery. In ANNALS OF SURGICAL ONCOLOGY (Vol. 32, pp. 775–776).
Douglas, Sasha, Samantha Thomas, Akiko Chiba, Maggie DiNome, Gayle DiLalla, E Shelley Hwang, Kendra Parrish, et al. “Contemporary trends in axillary surgery for ER-positive, HER2-negative breast cancer stratified by neoadjuvant endocrine therapy, neoadjuvant chemotherapy, or upfront surgery.” In ANNALS OF SURGICAL ONCOLOGY, 32:775–76, 2025.
Douglas S, Thomas S, Chiba A, DiNome M, DiLalla G, Hwang ES, et al. Contemporary trends in axillary surgery for ER-positive, HER2-negative breast cancer stratified by neoadjuvant endocrine therapy, neoadjuvant chemotherapy, or upfront surgery. In: ANNALS OF SURGICAL ONCOLOGY. 2025. p. 775–6.
Douglas, Sasha, et al. “Contemporary trends in axillary surgery for ER-positive, HER2-negative breast cancer stratified by neoadjuvant endocrine therapy, neoadjuvant chemotherapy, or upfront surgery.” ANNALS OF SURGICAL ONCOLOGY, vol. 32, 2025, pp. 775–76.
Douglas S, Thomas S, Chiba A, DiNome M, DiLalla G, Hwang ES, Parrish K, Rosenberger L, Plichta J, Wang T, van den Bruele AB. Contemporary trends in axillary surgery for ER-positive, HER2-negative breast cancer stratified by neoadjuvant endocrine therapy, neoadjuvant chemotherapy, or upfront surgery. ANNALS OF SURGICAL ONCOLOGY. 2025. p. 775–776.
Published In
ANNALS OF SURGICAL ONCOLOGY
EISSN
1534-4681
ISSN
1068-9265
Publication Date
2025
Volume
32
Start / End Page
775 / 776
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis